Parkman Healthcare Partners LLC Castle Biosciences Inc Transaction History
Parkman Healthcare Partners LLC
- $678 Million
- Q2 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 277,895 shares of CSTL stock, worth $7.74 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
277,895
Previous 367,408
24.36%
Holding current value
$7.74 Million
Previous $8.14 Million
25.67%
% of portfolio
0.89%
Previous 1.11%
Shares
9 transactions
Others Institutions Holding CSTL
# of Institutions
171Shares Held
25.5MCall Options Held
511KPut Options Held
130K-
Black Rock Inc. New York, NY3.04MShares$84.8 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.33MShares$64.9 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$43.9 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.5MShares$41.7 Million0.02% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.22MShares$33.9 Million0.44% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $733M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...